Genome-Scale CRISPR Knockout Screening Identifies BACH1 as a Key Regulator of Aflatoxin B₁-Induced Oxidative Damage

Jinfu Zhang,Siyi Hu,Changzhi Zhao,Yuan Zhou,Lu Zhang,Hailong Liu,Peng Zhou,Sheng Li,Liangliang Fu,Zhuqing Zheng,Yue Xiang,Xuewen Xu,Jinxue Ruan,Xinyun Li,Lvhui Sun,Gang Cao,Shuhong Zhao,Xu Wang,Shengsong Xie

DOI: https://doi.org/10.3390/antiox11091787

IF: 7.675

2022-01-01

Antioxidants

Abstract:Aflatoxin B-1 (AFB(1)) is amongst the mycotoxins commonly affecting human and animal health, raising global food safety and control concerns. The mechanisms underlying AFB(1) toxicity are poorly understood. Moreover, antidotes against AFB(1) are lacking. Genome-wide CRISPR/Cas9 knockout screening in porcine kidney cells identified the transcription factor BTB and CNC homolog 1 (BACH1) as a gene required for AFB(1) toxicity. The inhibition of BACH1 expression in porcine kidney cells and human hepatoma cells resulted in increased resistance to AFB(1). BACH1 depletion attenuates AFB(1)-induced oxidative damage via the upregulation of antioxidant genes. Subsequently, virtual structural screening identified the small molecule 1-Piperazineethanol, alpha-[(1,3-benzodioxol-5-yloxy)methyl] -4-(2-methoxyphenyl) (M2) as an inhibitor of BACH1. M2 and its analogues inhibited AFB(1)-induced porcine and human cell death in vitro, while M2 administration significantly improved AFB(1)-induced symptoms of weight loss and liver injury in vivo. These findings demonstrate that BACH1 plays a central role in AFB(1)-induced oxidative damage by regulating antioxidant gene expression. We also present a potent candidate small-molecule inhibitor in developing novel treatments for AFB(1) toxicity.